A critical discovery in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential malignant inhibitor protein is frequently lost in many types of tumors, causing https://privatebookmark.com/story21935893/mini-antibodies-restore-the-p53-protein-the-promising-hope-for-tumor-management